ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Import this data to Google Sheets with:

=jivedata("ARWR","financials")

Full statements spill as a table. For one cell: =jivedata("ARWR","Revenue") or =jivedata("ARWR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

ARROWHEAD PHARMACEUTICALS, INC.

ARWR • CIK 0000879407

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Property, Plant and Equipment, Net	$290,262	$386,032	$382,515	$373,301
Finite-Lived Intangible Assets, Net	$10,262	$8,562	$6,861	$5,586
Operating Lease, Right-of-Use Asset	$45,297	$45,255	$43,891	$55,667
Other Assets, Noncurrent	$210	$4,482	$1,389	$6,048
Assets	$765,552	$1,139,802	$1,385,295	$2,112,013
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$110,891	$102,685	$226,548	$54,759
Accounts Receivable, after Allowance for Credit Loss, Current	$0	—	$6,824	$8,556
Debt Securities, Available-for-sale, Current	$292,735	$578,276	$692,818	$1,547,201
Prepaid Expense, Current	$8,813	$9,537	$10,933	$25,373
Other Assets, Current	$7,082	$4,973	$13,516	$35,522
Assets, Current	$419,521	$695,471	$950,639	$1,671,411
Accounts Payable, Current	$35,866	$11,388	$17,674	$27,776
Accrued Liabilities, Current	$39,763	$63,017	$90,419	$86,174
Employee-related Liabilities, Current	$17,963	$21,989	$26,895	$23,455
Operating Lease, Liability, Current	$10,563	$6,342	$7,289	$5,322
Contract with Customer, Liability, Current	$866	$0	$2,399	$94,596
Line of Credit, Current	—	—	$40,000	$40,000
Other Liabilities, Current	$435	$432	$10,811	$6,023
Liabilities, Current	$105,456	$103,168	$195,487	$283,346
Operating Lease, Liability, Noncurrent	$104,608	$111,027	$104,112	$114,298
Long-term Line of Credit, Noncurrent	—	$393,183	$214,883	$141,366
Liabilities, Noncurrent	$372,934	$845,571	$686,392	$1,362,626
Common Stock, Value, Issued	$200	$217	$231	$237
Additional Paid in Capital, Common Stock	$1,300,395	$1,806,000	$2,139,725	$2,443,074
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-3,222	$4,750	$6,443	$-1,234
Retained Earnings (Accumulated Deficit)	$-1,026,030	$-1,625,523	$-1,627,154	$-1,923,355
Treasury Stock, Common, Value	—	—	$53,193	$53,193
Stockholders' Equity Attributable to Parent	$271,343	$185,444	$466,052	$465,529
Stockholders' Equity Attributable to Noncontrolling Interest	$15,819	$5,619	$37,364	$512
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$287,162	$191,063	$503,416	$466,041
Common Stock, Shares Authorized	290,000,000	290,000,000	290,000,000	290,000,000
Common Stock, Shares, Issued	107,312,000	124,376,000	135,702,000	143,796,000
Treasury Stock, Common, Shares	—	—	2,661,000	2,661,000
Property, Plant and Equipment, Gross	$332,213	$444,053	$462,684	$470,540
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$41,951	$58,021	$80,169	$97,239
Depreciation, Depletion and Amortization	$10,700	$16,900	$22,200	$18,100
Accrued Income Taxes, Current	—	—	$20,799	$0
Other Accrued Liabilities, Current	—	$7,391	$7,717	$10,964

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-209,275	$-609,693	$30,114	$-272,128
Net Cash Provided by (Used in) Operating Activities	$-153,890	$-462,851	$179,552	$-59,055
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$3,008	$-12,403	$124,264	$-76,590
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-122	$4,197	$-401	$-227
Share-based Payment Arrangement, Noncash Expense	$78,130	$73,968	$63,366	$70,000
Payments to Acquire Property, Plant, and Equipment	$176,737	$141,469	$22,666	$16,056
Depreciation, Depletion and Amortization, Nonproduction	$12,493	$18,595	$23,928	$25,803
Payments to Acquire Investments	$246,141	$720,947	$796,258	$899,442
Investment Income, Net, Amortization of Discount and Premium	$2,017	$3,244	$5,789	$5,366
Proceeds from Sale, Maturity and Collection of Investments	$326,723	$442,344	$689,630	$686,794
Net Cash Provided by (Used in) Investing Activities	$-96,155	$-420,072	$-129,294	$-801,722
Paid-in-Kind Interest	—	$9,317	$63,325	$58,925
Realized Investment Gains (Losses)	—	$-80	$0	$36
Proceeds from Stock Options Exercised	$3,053	$2,389	$3,983	$13,270
Proceeds from Issuance of Common Stock	—	$429,265	$241,388	$288,220
Proceeds from Issuance of Warrants	—	—	$25,000	$99,998
Payments of Debt Issuance Costs	—	$3,134	$5,000	$18,716
Proceeds from Long-term Lines of Credit	—	$392,000	$0	$0
Repayments of Long-term Lines of Credit	—	—	$201,625	$117,891
Proceeds from Lines of Credit	—	—	$10,260	$3,162
Net Cash Provided by (Used in) Financing Activities	$253,053	$870,520	$74,006	$784,187
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$110,891	$102,685	$226,548	$374,302
Interest Paid, Excluding Capitalized Interest, Operating Activities	$0	—	$19	$0
Income Taxes Paid, Net	$0	$-3,744	$814	$22,320
Capital Expenditures Incurred but Not yet Paid	—	$4,206	$277	$1,015
Increase (Decrease) in Accounts Receivable	$-1,410	$0	$56,967	$49,033
Increase (Decrease) in Prepaid Expense and Other Assets	$-11,603	$1,664	$9,939	$17,537
Increase (Decrease) in Accounts Payable	$32,998	$-5,536	$6,286	$-5,396
Increase (Decrease) in Accrued Liabilities	$-14,965	$32,117	$41,497	$18,327
Increase (Decrease) in Contract with Customer, Liability	$-129,183	$-866	$2,399	$103,360
IncreaseDecreaseInOperatingLeaseLiability	$46,590	$2,240	$-4,605	$-4,744
Increase (Decrease) in Other Operating Assets and Liabilities, Net	—	—	$-3,094	$2,487

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ARWR","financials")

Full statements spill as a table. For one cell: =jivedata("ARWR","Revenue") or =jivedata("ARWR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.